Primary Results of the EVOLVE Short DAPT Study: Evaluation of 3-Month Dual Antiplatelet Therapy in High Bleeding Risk Patients Treated With a Bioabsorbable Polymer-Coated Everolimus-Eluting Stent.

Absorbable Implants Coronary Artery Disease / drug therapy Drug Therapy, Combination Drug-Eluting Stents Everolimus / adverse effects Humans Percutaneous Coronary Intervention / adverse effects Platelet Aggregation Inhibitors / adverse effects Polymers Treatment Outcome
aspirin everolimus percutaneous coronary intervention stent thrombosis

Journal

Circulation. Cardiovascular interventions
ISSN: 1941-7632
Titre abrégé: Circ Cardiovasc Interv
Pays: United States
ID NLM: 101499602

Informations de publication

Date de publication:
03 2021
Historique:
pubmed: 2 3 2021
medline: 28 9 2021
entrez: 1 3 2021
Statut: ppublish

Résumé

[Figure: see text].

Identifiants

DOI: 10.1161/CIRCINTERVENTIONS.120.010144 PMID: 33641374
pubmed: 33641374
doi: 10.1161/CIRCINTERVENTIONS.120.010144
doi:

Substances chimiques

Platelet Aggregation Inhibitors 0
Polymers 0
Everolimus 9HW64Q8G6G

Banques de données

ClinicalTrials.gov
['NCT02605447']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e010144

Commentaires et corrections

Type : CommentIn

Auteurs

Ajay J Kirtane (AJ)

Columbia University Irving Medical Center/NewYork-Presbyterian Hospital and the Cardiovascular Research Foundation, New York (A.J.K.).

Robert Stoler (R)

Baylor Scott & White Heart and Vascular Hospital, Dallas, TX (R.S., J.W.C.).

Robert Feldman (R)

MediQuest Research at AdventHealth Ocala, FL (R.F.).

Franz-Josef Neumann (FJ)

University of Freiburg, Universitats-Herzzentrum Freiburg, Bad Krozingen, Germany (F.-J.N.).

Loukas Boutis (L)

North Shore University Hospital, Manhasset, NY (L.B.).

Naeem Tahirkheli (N)

Oklahoma Heart Hospital, Oklahoma City (N.T.).

Ralph Toelg (R)

Herzzentrum Segeberger Kliniken, Bad Segeberg, Germany (R.T.).

Islam Othman (I)

Duke University Health System, Durham, NC (I.O.).

Bernardo Stein (B)

Morton Plant Mease Healthcare System, Clearwater, FL (B.S.).

James W Choi (JW)

Baylor Scott & White Heart and Vascular Hospital, Dallas, TX (R.S., J.W.C.).

Stephan Windecker (S)

Bern University Hospital, Inselspital, University of Bern, Switzerland (S.W.).

Robert W Yeh (RW)

Beth Israel Deaconess Medical Center, Boston, MA (R.W.Y.).

Harold L Dauerman (HL)

University of Vermont Medical Center, Burlington (H.L.D.).

Matthew J Price (MJ)

Scripps Clinic, La Jolla, CA (M.J.P.).

Paul Underwood (P)

Boston Scientific Corporation, Marlborough, MA (P.U., D.A., I.M.).

Dominic Allocco (D)

Boston Scientific Corporation, Marlborough, MA (P.U., D.A., I.M.).

Ian Meredith (I)

Boston Scientific Corporation, Marlborough, MA (P.U., D.A., I.M.).

Dean J Kereiakes (DJ)

Lindner Center for Research and Education at Christ Hospital, Cincinnati, OH (D.J.K.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Équipement et fournitures › Prothèses et implants › Implant résorbable › Primary Results of the EVOLVE Short DAPT...
questionsmedicales.fr › Maladies cardiovasculaires › Maladies vasculaires › Ischémie myocardique › Maladie coronarienne › Maladie des artères coronaires › Primary Results of the EVOLVE Short DAPT...
questionsmedicales.fr › Thérapeutique › Traitement médicamenteux › Association de médicaments › Primary Results of the EVOLVE Short DAPT...
questionsmedicales.fr › Équipement et fournitures › Prothèses et implants › Endoprothèses › Endoprothèses à élution de substances › Primary Results of the EVOLVE Short DAPT...
questionsmedicales.fr › Composés chimiques organiques › Lactones › Sirolimus › Évérolimus › Primary Results of the EVOLVE Short DAPT...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Primary Results of the EVOLVE Short DAPT...
questionsmedicales.fr › Procédures de chirurgie opératoire › Interventions chirurgicales mini-invasives › Procédures endovasculaires › Intervention coronarienne percutanée › Primary Results of the EVOLVE Short DAPT...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Agents hématologiques › Antiagrégants plaquettaires › Primary Results of the EVOLVE Short DAPT...
questionsmedicales.fr › Technologie, industrie et agriculture › Produits manufacturés › Matériaux biomédicaux et dentaires › Polymères › Primary Results of the EVOLVE Short DAPT...
questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Qualité des soins de santé › Mécanismes d'évaluation des soins de santé › Évaluation des résultats et des processus en soins de santé › Évaluation de résultat (soins) › Résultat thérapeutique › Primary Results of the EVOLVE Short DAPT...